Keywords: BOS، سندرم برونشیولیت obliterans; BAL, bronchoalveolar lavage; BALF, bronchoalveolar lavage fluid; BOS, bronchiolitis obliterans syndrome; CF, Cystic Fibrosis; CRS, chronic rhinosinusitis; CTSS, cathepsin S; ECM, extracellular matrix; IFN, interferon; IL, interleukin; LAW, lower airways;
مقالات ISI BOS، سندرم برونشیولیت obliterans (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: BOS، سندرم برونشیولیت obliterans; AMR, antibody mediated rejection; BAL, bronchoalveolar lavage; BOS, bronchiolitis obliterans syndrome; CDC, complement-dependent cytotoxicity; CF, cystic fibrosis; CLAD, chronic lung allograft dysfunction; CMV, cytomegalovirus; CT, computed tomography; DA
Keywords: BOS، سندرم برونشیولیت obliterans; BOS, bronchiolitis obliterans syndrome; GER, gastroesophageal reflux; GERD, gastroesophageal reflux disease; HRCT, high-resolution CT; IPF, idiopathic pulmonary fibrosis
Lung Transplantation for Hypersensitivity Pneumonitis
Keywords: BOS، سندرم برونشیولیت obliterans; BOS, bronchiolitis obliterans syndrome; fBOS, freedom from bronchiolitis obliterans syndrome; HP, hypersensitivity pneumonitis; ILD, interstitial lung disease; IPF, idiopathic pulmonary fibrosis; LT, lung transplantation; TBBx, transbronchial biopsy speci
BAL neutrophilia in azithromycin-treated lung transplant recipients: Clinical significance
Keywords: BOS، سندرم برونشیولیت obliterans; α-1ATD, alpha-1-antitrypsin deficiency; AR, acute rejection; ARAD, azithromycin responsive allograft dysfunction; BAL, broncho-alveolar lavage; BOS, bronchiolitis obliterans syndrome; CF, cystic fibrosis; CLAD, chronic lung allograft syndrome; COPD, chron
Role of defensins in the pathogenesis of chronic lung allograft rejection
Keywords: BOS، سندرم برونشیولیت obliterans; AAT, α-1-antitrypsin; BAL, bronchoalveolar lavage; BOS, bronchiolitis obliterans syndrome; Col-V, Collagen-V; DSA, donor specific antibodies; ELISA, enzyme-linked immunosorbent assay; EGF, epidermal growth factor; HAEC, human aortic endothelial cells; HBD
Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients
Keywords: BOS، سندرم برونشیولیت obliterans; 12BAL, bronchoalveolar lavage; BOS, bronchiolitis obliterans syndrome; CMV, cytomegalovirus; ET, endothelin; FEV1, forced expiratory volume in 1 second; IL, interleukin; PGD, primary graft dysfunction
Diagnosis and treatment of antibody mediated rejection in lung transplantation: A retrospective case series
Keywords: BOS، سندرم برونشیولیت obliterans; AMR, Antibody mediated rejection; BOS, bronchiolitis obliterans syndrome; BAL, bronchoalveolar lavage; c4d, degradation product of complement component 4b; DSA, donor specific antibody; FEV1, forced expiratory volume in one second; HLA, human leukocyte an
Inhibiting CXCL12 blocks fibrocyte migration and differentiation and attenuates bronchiolitis obliterans in a murine heterotopic tracheal transplant model
Keywords: BOS، سندرم برونشیولیت obliterans; α-SMA, α-smooth muscle actin; BOS, bronchiolitis obliterans syndrome; Col1, collagen 1; IPF, idiopathic pulmonary fibrosis; mTOR, mammalian target of rapamycin12
Aspiration, Localized Pulmonary Inflammation, and Predictors of Early-Onset Bronchiolitis Obliterans Syndrome after Lung Transplantation
Keywords: BOS، سندرم برونشیولیت obliterans; ACR, acute cellular rejection; A1AT, α1-antitrypsin; BALF, bronchoalveolar fluid; BOS, bronchiolitis obliterans syndrome; GERD, gastroesophageal reflux disease; GM-CSF, granulocyte-macrophage colony-stimulating factor; IPO-10, interferon-γ–induced protein
Dissection of inflammatory processes using chemokine biology: Lessons from clinical models
Keywords: BOS، سندرم برونشیولیت obliterans; B1a, CD5(+) B-1 cells; BOS, bronchiolitis obliterans syndrome; CD, cluster determinant; CNS, central nervous system; DC, dendritic cell; DSS, dextran sodium sulfate; EAE, experimental autoimmune encephalomyelitis; GAG, glycosaminoglycan; GVHD, graft-versu
Role of antibodies to self-antigens in chronic allograft rejection: Potential mechanism and therapeutic implications
Keywords: BOS، سندرم برونشیولیت obliterans; Abs, antibodies; AEC, airway epithelial cells; AMR, antibody mediated rejection; APC, antigen presenting cells; AT1, angiotensis II type 1; BOS, bronchiolitis obliterans syndrome; CAN, chronic allograft nephropathy; CAV, cardiac allograft vasculopathy; Co
Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation
Keywords: BOS، سندرم برونشیولیت obliterans; ACR, acute cellular rejection; BOS, bronchiolitis obliterans syndrome; CCL2, chemokine ligand 2; CF, cystic fibrosis; CI, confidence interval; COPD, chronic obstructive pulmonary disease; IPF, idiopathic pulmonary fibrosis; IQR, interquartile range; IRI,
Anti-IL-23 antibody blockade of IL-23/IL-17 pathway attenuates airway obliteration in rat orthotopic tracheal transplantation
Keywords: BOS، سندرم برونشیولیت obliterans; OB, Obliterative bronchiolitis; OAD, Obliterative airway disease; BOS, Bronchiolitis obliterans syndrome; SPF, Specific pathogen free; BN, Brown–Norway rat; Lew, Lewis rat; Anti-IL-23, Goat anti rat IL-23 antibody; IgG, Goat isotype immunoglobulin; FACS,
Paediatric Interstitial Lung Disease: Classification and Definitions
Keywords: BOS، سندرم برونشیولیت obliterans; ABCA3, ATPase binding cassette transporter subfamily A3 gene; ACD/MPV, alveolar capillary dysplasia with misalignment of pulmonary veins; AGA, alveolar growth abnormality; AIP, acute interstitial pneumonia; BOS, bronchiolitis obliterans syndrome; CFA, cry
Short- and long-term outcomes of 1000 adult lung transplant recipients at a single center
Keywords: BOS، سندرم برونشیولیت obliterans; BOS, bronchiolitis obliterans syndrome; COPD, chronic obstructive pulmonary disease; DCD, donation after cardiac death; PGD, primary graft dysfunction
Endothelin-1 is a useful biomarker for early detection of bronchiolitis obliterans in lung transplant recipients
Keywords: BOS، سندرم برونشیولیت obliterans; BAL, bronchoalveolar lavage; BO, bronchiolitis obliterans; BOS, bronchiolitis obliterans syndrome; CI, confidence interval; CMV, cytomegalovirus; ET-1, endothelin-1; FEV1, forced expiratory volume in 1 second; OR, odds ratio; PCR, polymerase chain reactio
Lung transplantation with donation after cardiac death donors: Long-term follow-up in a single center
Keywords: BOS، سندرم برونشیولیت obliterans; 12BDD, brain-dead donor; BLT, bilateral lung transplantation; BOS, bronchiolitis obliterans syndrome; DCD, donation after cardiac death; ECMO, extracorporeal membrane oxygenation; iNO, Inhaled nitric oxide; IQR, interquartile range; ISHLT, International S
Detection of Epstein–Barr virus DNA in peripheral blood is associated with the development of bronchiolitis obliterans syndrome after lung transplantation
Keywords: BOS، سندرم برونشیولیت obliterans; EBV, Epstein–Barr virus; BOS, bronchiolitis obliterans syndrome; CMV, cytomegalovirus; HAdV, human adenovirus; LTR, lung and heart–lung transplant recipients; PTLD, posttransplant lymphoproliferative disease; PCR, Polymerase chain reaction; IgG, Immunoglo
In vitro modeling of nonhypoxic cold ischemia–reperfusion simulating lung transplantation
Keywords: BOS، سندرم برونشیولیت obliterans; AM, alveolar macrophage; BOS, bronchiolitis obliterans syndrome; ERK, extracellular signal-regulated kinase; HMVEC, human pulmonary microvascular endothelial cell; HUVEC, human umbilical vein endothelial cell; IκBα, inhibitor of nuclear factor κB,α; IL, i
Bronchiolitis obliterans in lung transplantation: the good, the bad, and the future
Keywords: BOS، سندرم برونشیولیت obliterans; APC, antigen presenting cell; BOS, bronchiolitis obliterans syndrome; DC, dendritic cell; HLA, human leukocyte antigen; HTT, heterotopic tracheal transplant; I/R, ischemia/reperfusion; ISHLT, International Society of Heart and Lung Transplantation; LB, ly
CXCR2 antagonists for the treatment of pulmonary disease
Keywords: BOS، سندرم برونشیولیت obliterans; CXCR2; Neutrophil; Mucus; Fibrosis; COPD; AsthmaALI, acute lung injury; ARDS, acute respiratory distress syndrome; BALF, bronchoalveolar lavage fluid; BOS, bronchiolitis obliterans syndrome; BPD, bronchopulmonary dysplasia; CFTR, cystic fibrosis transmemb
The value of D-dimer in lung transplant recipients with bronchiolitis obliterans syndrome
Keywords: BOS، سندرم برونشیولیت obliterans; BOS, bronchiolitis obliterans syndrome; FEV1, forced expiratory volume in 1 s; 6MWT, 6-min walk test; PAI-I, plasminogen activator inhibitor; TPA, tissue plasminogen activation; VO2, oxygen consumptionD-dimer; Lung transplantation; Bronchiolitis obliteran
Lung transplantation in older patients?
Keywords: BOS، سندرم برونشیولیت obliterans; 12ATG, anti-thymocyte globulin; BOS, bronchiolitis obliterans syndrome; CMV, cytomegalovirus; CPB, cardiopulmonary bypass; Fio2, fraction of inspired oxygen; IPF, interstitial pulmonary fibrosis; ISHLT, International Society for Heart and Lung Transplanta
Effects of induction immunosuppression regimen on acute rejection, bronchiolitis obliterans, and survival after lung transplantation
Keywords: BOS، سندرم برونشیولیت obliterans; AR, acute rejection; AT, antithymocyte globulin; BOS, bronchiolitis obliterans syndrome; CMV, cytomegalovirus; HR, hazard ratio; IL-2R, interleukin 2 receptor; ISHLT, International Society for Heart and Lung Transplantation; MMF, mycophenolate mofetil; PT
Angiogenesis: A potentially critical part of remodelling in chronic airway diseases?
Keywords: BOS، سندرم برونشیولیت obliterans; BAL, Bronchoalveolar Lavage; COPD, Chronic Obstructive Pulmonary Disease; BOS, Bronchiolitis Obliterans Syndrome; FEV1, Forced Expiratory Volume in 1 s; VEGF, Vascular Endothelial Growth Factor; VEGF R, VEGF Receptor; AHR, Airway hyper reactivity; ICS, In
Living-Donor Lobar Lung Transplantation for Pulmonary Arterial Hypertension After Failure of Epoprostenol Therapy
Keywords: BOS، سندرم برونشیولیت obliterans; BOS, bronchiolitis obliterans syndrome; CLT, cadaveric lung transplantation; FVC, forced vital capacity; IPAH, idiopathic pulmonary arterial hypertension; LDLLT, living-donor lobar lung transplantation; PAH, pulmonary arterial hypertension; PCH, pulmonary
Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures
Keywords: BOS، سندرم برونشیولیت obliterans; 9; 11; 12BA, blood albumin; BOS, bronchiolitis obliterans syndrome; CC, core cooling; CI, confidence interval; dPGD, death caused by primary graft dysfunction; EC, Euro–Collins; IQR, interquartile range; LPD, low potassium dextran; LTx, lung transplantati
Extended donor criteria in lung transplantation: Impact on organ allocation
Keywords: BOS، سندرم برونشیولیت obliterans; 12BLT, bilateral lung transplantation; BOS, bronchiolitis obliterans syndrome; CPB, cardiopulmonary bypass; CXR, chest roentgenogram; Fio2, fraction of inspired oxygen; ITU, intensive therapy unit; PGD, primary graft dysfunction; SLT, single lung transpla
Pathologic Correlates of Bronchiolitis Obliterans Syndrome in Pulmonary Retransplant Recipients
Keywords: BOS، سندرم برونشیولیت obliterans; biopsy; bronchiolitis obliterans; heart-lung transplantation; histology; homologous transplantation; lung transplantation; pathology; radiographyBO, bronchiolitis obliterans; BOS, bronchiolitis obliterans syndrome; EFI, epithelial-fibrotic-inflammatory; G
Chronic aspiration of gastric fluid accelerates pulmonary allograft dysfunction in a rat model of lung transplantation
Keywords: BOS، سندرم برونشیولیت obliterans; 9; 11; 12APC, antigen-presenting cell; BOS, bronchiolitis obliterans syndrome; F344, Fischer F344; GERD, gastroesophageal reflux disease; IL, interleukin; OB, bronchiolitis obliterans; PA, pulmonary artery; PV, pulmonary vein; TGF, transforming growth fac
ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets
Keywords: BOS، سندرم برونشیولیت obliterans; BALF, bronchoalveolar lavage fluid; BOS, bronchiolitis obliterans syndrome; COPD, chronic obstructive pulmonary disease; CXCL1, melanoma growth stimulating activity, alpha; CXCL5, epithelial neutrophil activating protein; CXCL8, interleukin-8; CXCR1, CXC